3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Sarcoma
35
Osteosarcoma
22
Central Nervous System Neoplasms
6
Breast Neoplasms
6
Stomach Neoplasms
5
Ovarian Neoplasms
5
Head and Neck Neoplasms
5
Glioblastoma
5
Colorectal Neoplasms
5
Colonic Neoplasms
5
Pancreatic Neoplasms
4
Neuroblastoma
4
Gliosarcoma
4
Glioma
4
Carcinoma, Non-Small-Cell Lung
4
Brain Neoplasms
4
Astrocytoma
4
Wilms Tumor
3
Sarcoma, Ewing
3
Rhabdomyosarcoma
3
Rectal Neoplasms
3
Neuroectodermal Tumors, Primitive, Peripheral
3
Neoplasms
3
Neoplasm Metastasis
3
Melanoma
3
Esophageal Neoplasms
3
Ependymoma
3
Desmoplastic Small Round Cell Tumor
3
Choroid Plexus Neoplasms
3
Carcinoma, Ovarian Epithelial
3
Interventions
Doxorubicin
25
Radiotherapy
16
Ifosfamide
14
Trabectedin
10
pazopanib
6
ribociclib
5
pembrolizumab
5
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Gemcitabine
5
Biopsy
5
palbociclib
4
Radiation
4
Docetaxel
4
Chemotherapy, Adjuvant
4
selinexor
3
liposomal doxorubicin
3
eribulin
3
abemaciclib
3
X-Rays
3
Vincristine
3
Neoadjuvant Therapy
3
Imatinib Mesylate
3
Filgrastim
3
Etoposide
3
Cyclophosphamide
3
toripalimab
2
temsirolimus
2
romidepsin
2
pegfilgrastim
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liposarcoma
×
Cisplatin
×
Sarcoma
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled